Safety of Ustekinumab in Patients 65 Years or Older With Inflammatory Bowel Disease: A Propensity-Based Match Analysis

被引：0
|
作者：
Kochhar, Gursimran S. [1 ]
Desai, Aakash [2 ]
Dulai, Parambir S. [1 ,3 ]
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
[2] Case Western Reserve Univ, MetroHlth Med Ctt, Cleveland, OH USA
[3] Northwestern Univ, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1003
引用
收藏
页码：S727 / S727
页数：1
相关论文
共 50 条
  • [1] Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study
    Burgevin, Alice
    Caron, Benedicte
    Sasson, Alexa
    Luc, Amandine
    Netter, Patrick
    Baumann, Cedric
    Ananthakrishnan, Ashwin N.
    Peyrin-Biroulet, Laurent
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [2] Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults With Inflammatory Bowel Disease
    Sachar, Moniyka
    Fernandez, Cristina
    Beaty, William
    Rojanasopondist, Pakdee
    Delau, Olivia
    Li, Alice
    Murphy, Megan
    Axelrad, Jordan
    Hong, Simon J.
    Holmer, Ariela
    Chang, Shannon
    Hudesman, David
    Katz, Seymour
    Malter, Lisa
    Faye, Adam S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S866 - S867
  • [3] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
    Ghosh, Subrata
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Godwin, Bridget
    Marano, Colleen
    Miao, Ye
    Ma, Tony
    Loftus, Edward, V
    Sandborn, William J.
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1091 - 1101
  • [4] Comparison of Characteristics and Inpatient Outcomes of Patients With Inflammatory Bowel Disease and Colon Cancer: A Propensity-Based Nationwide Inpatient Sample Study
    Subedi, Prashant
    Paudel, Mukesh S.
    Gayam, Vijay
    Mandal, Amrendra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [5] Safety of ustekinumab in inflammatory bowel diseases (IBD): pooled safety analysis through 5 years in Crohn
    Sandborn, William J.
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Lynch, John
    Marano, Colleen
    Miao, Ye
    Tikhonov, Ilia
    Danese, Silvio
    Sands, Bruce E.
    Ghosh, Subrata
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 108 - 108
  • [6] Safety and Efficacy of Ustekinumab in the Inflammatory Bowel Disease of Chronic Granulomatous Disease
    Bhattacharya, Sumona
    Marciano, Beatriz E.
    Malech, Harry L.
    Quezado, Martha
    Holland, Steven M.
    De Ravin, Suk See
    Zerbe, Christa S.
    Heller, Theo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 461 - +
  • [7] Efficacy and Safety of Infliximab in Older Inflammatory Bowel Disease Patients
    Lindenmeyer, Christina
    Moleski, Stephanie
    Whitsett, Maureen
    Kozuch, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S509 - S509
  • [8] Mortality in Inflammatory Bowel Disease Patients Under 65 Years of Age
    O'Toole, Aoibhlinn M.
    Walsh, Paul M.
    Keegan, Denise
    Byrne, Kathryn
    Doherty, Glen A.
    O'Donoghue, Diarmuid P.
    Mulcahy, Hugh
    GASTROENTEROLOGY, 2013, 144 (05) : S649 - S649
  • [9] Mortality in inflammatory bowel disease patients under 65 years of age
    O'Toole, Aoibhlinn
    Walsh, Paul
    Keegan, Denise
    Byrne, Kathryn
    Doherty, Glen
    O'Donoghue, Diarmuid
    Mulcahy, Hugh
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (07) : 814 - 819
  • [10] Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
    Wils, Pauline
    Seksik, Philippe
    Stefanescu, Carmen
    Nancey, Stephane
    Allez, Matthieu
    de Chambrun, Guillaume Pineton
    Altwegg, Romain
    Gilletta, Cyrielle
    Vuitton, Lucine
    Viennot, Stephanie
    Serrero, Melanie
    Fumery, Mathurin
    Savoye, Guillaume
    Collins, Michael
    Goutorbe, Felix
    Brixi, Hedia
    Bouguen, Guillaume
    Tavernier, Noemie
    Boualit, Medina
    Amiot, Aurelien
    Abitbol, Vered
    Laharie, David
    Pariente, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (04) : 460 - 470
12345